Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NGVT | Employee Stock Option (right-to-buy) | Award | $0 | +19.3K | $0.00 | 19.3K | Feb 26, 2021 | Common Stock | 19.3K | $69.48 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). This amendment is being filed solely to correct the exercise price and to correct the signature line of the prior report. |
F2 | These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024. |